- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America
- Join Join
On behalf of the Connecticut Chapter of Americans for Safe Access, I’d like to formally announce our chapter’s newest initiative, amending the list of “Debilitating Illnesses” that qualify under the Connecticut Medical Marijuana Program to include:
- Arthritis/ Osteoarthritis
- Chronic Pain
This initiative will include hosting a petition for each individual condition, as well as submitting an official Petition to Add a Medical Condition, Medical Treatment, or Disease to the List of Debilitating Condition to the Connecticut Department of Consumer Protection. The official petition that CTASA will end up submitting will require extensive research and evidence regarding current treatment, adverse effects of said treatment, clinical research studies that support the use of medicinal cannabis to treat these conditions, as well as doctors’ letters of endorsement for each condition we wish to add. The petition and information will be compiled and organized by Connecticut for Safe Access and should be ready to be turned in within a two month time span.
As Chair of Connecticut for Safe Access and as an active business owner within the Medical Marijuana Industry in both Connecticut and New York, I know that there is a dire need for unity, organization, and a strong union presence within all sectors of the Connecticut Medical Marijuana Industry. This initiative will be designed to address all of these complex issues, as we aim to work together as an industry and include all stakeholders to better the Connecticut Medical Marijuana Program.